𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study

✍ Scribed by Muscato, Joseph J.; Cirrincione, Constance; Clamon, Gerald; Perry, Michael C.; Omura, George; Berkowitz, Irving; Reid, Thomas; Herndon, James E.; Green, Mark R.

Book ID
121976581
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
559 KB
Volume
13
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of etoposide and cisplati
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: A cancer and leukemia group B study
✍ Graziano, Stephen L. ;Lee, Kewchang ;Propert, Kathleen J. ;Tinsley, Roger ;Hayes πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 466 KB πŸ‘ 1 views

## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirty‐five evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin